title: Esophageal aspergillosis after bone marrow transplant.
abstract: The prolonged immune suppression associated with bone marrow transplants predisposes to fungal infections including Aspergillus. Disseminated aspergillosis occurs in up to 60% of patients with invasive pulmonary aspergillosis; sites of involvement include the brain, gastrointestinal tract, kidney, liver, thyroid, heart, and spleen. There is only one report of isolated esophageal aspergillosis. A recent acute myelogenous leukemia patient had isolated esophageal aspergillosis after bone marrow transplantation which was successfully treated with amphotericin B.
authors.affiliation: Bone Marrow Transplantation Center, St Mary's Hospital, Catholic University Medical College, Seoul, Korea.
authors.forename: J H
authors.initials: JH
authors.lastname: Choi
authors.forename: J H
authors.initials: JH
authors.lastname: Yoo
authors.forename: I J
authors.initials: IJ
authors.lastname: Chung
authors.forename: D W
authors.initials: DW
authors.lastname: Kim
authors.forename: C W
authors.initials: CW
authors.lastname: Han
authors.forename: W S
authors.initials: WS
authors.lastname: Shin
authors.forename: W S
authors.initials: WS
authors.lastname: Min
authors.forename: C W
authors.initials: CW
authors.lastname: Park
authors.forename: C C
authors.initials: CC
authors.lastname: Kim
authors.forename: D J
authors.initials: DJ
authors.lastname: Kim
mesh_terms: D000328:Adult; D001228:Aspergillosis / Q000209:etiology*; D016026:Bone Marrow Transplantation / Q000009:adverse effects*; D004935:Esophageal Diseases / Q000209:etiology*; D006801:Humans; D008297:Male